Xylem (XYL) Tops Q4 EPS by 12c, Provides FY23 Guidance

Xylem (NYSE: XYL) reported Q4 EPS of $0.92, $0.12 better than the analyst estimate of $0.80. Revenue for the quarter came in at $1.5 billion versus the consensus estimate of $1.41 billion.

GUIDANCE:

Xylem sees FY2023 EPS of $3.00-$3.25, versus the consensus of $3.18.

For earnings history and earnings-related data on Xylem (XYL) click here.

You May Also Be Interested In

• Rivian reports record Q3 deliveries, beats estimates, shares rise
• Cuprina to buy seven-clinic Singapore healthcare group for S$4M
• Reaction roundup: Experts, analysts weigh in on September jobs report